News Wire

Updated results from a global clinical trial of the CAR T-cell therapy tisagenlecleucel (Kymriah, Novartis) show that children and young adults continued to show high rates of durable, complete remission of their high-risk form of acute lymphoblastic leukemia (ALL), according to a study published in…
Scientists in Japan and Australia have developed a blood test that can identify people who have high levels of a protein associated with Alzheimer's disease. If confirmed by further research, this long-sought test could help in the increasingly desperate search for therapies that halt the progression…
Once-weekly semaglutide (Ozempic, Novo Nordisk) led to greater reductions in HbA1c and body weight compared to dulaglutide (Trulicity, Eli Lilly) in the SUSTAIN 7 trial, according to results published in The Lancet Diabetes & Endocrinology. SUSTAIN 7 investigated the efficacy and safety of 0.5 mg semaglutide…
In an update on pharmaceutical pipeline projects tucked inside its financial results, FierceBiotech reports, Swiss drugmaker Roche announced that it was pulling the plug on several early- and late-stage candidates. The casualties: Lampalizumab (RG7417), a phase 3 drug that last fall failed two tests:…
The FDA is adding a boxed warning to obeticholic acid (Ocaliva, Intercept Pharmaceuticals, Inc.) in an effort to prevent incorrect dosing of the liver-disease medication in patients with moderate-to-severe primary biliary cholangitis (PBC). Obeticholic acid has been incorrectly dosed daily instead of…
Sarah Kliff at Vox had the best tweet about this morning’s announcement that Amazon, Berkshire Hathaway, and JPMorgan Chase were forming a new health care company. “Alexa, what is this new Amazon health care company?" https://t.co/oAAI0R4JQH — Sarah Kliff (@sarahkliff) January 30, 2018 The lack…
The FDA has awarded a breakthrough therapy designation to the investigational oral drug balovaptan (previously known as RG7314, Roche), a vasopressin 1a (V1a) receptor antagonist for individuals with autism spectrum disorder (ASD). Balovaptan has shown the potential to improve social interaction and…
The National Institutes of Health (NIH) is teaming with government, biopharmaceutical, life science, and nonprofit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP…
A new study at Columbia University Irving Medical Center (CUIMC) challenges the popular notion that psychiatric medications are overprescribed in U.S. children and adolescents. When the researchers compared prescribing rates with prevalence rates for the most common psychiatric disorders in children,…
Amazon.com, Inc., Berkshire Hathaway, and JPMorgan Chase & Co. will form a health care company aimed at cutting costs for their U.S. employees, the three partners have announced. Reuters reports that the news sent shares in the broad health care sector sharply lower. The independent company will be…
Increased reimbursements under Medicare Part B overall could offset potential losses for hospitals under changes to the 340B discount program, according to a new analysis. FierceHealthcare reports that consulting firm Avalere Health analyzed hospital-level data from the Centers for Medicare and Medicaid…
Just how bad a flu season are we having? Without a crystal ball, it’s impossible to predict the final toll. But just about any way you crunch the numbers, the prognosis is grim. “Most people with influenza are being infected with the H3N2 influenza virus. And in seasons where H3N2 is the main cause…
President Donald Trump said prescription drug prices will come “rocketing down” under the leadership of the new secretary of Health and Social Services (HHS), according to a report from The Hill. “We have to get the prices of prescription drugs way down and unravel the tangled web of special interest…
The FDA has rejected the new drug application (NDA) for Linhaliq (Aradigm Corporation) as a treatment for non-cystic fibrosis bronchiectasis (NCFBE) patients who have chronic lung infections with Pseudomonas aeruginosa. Aradigm said it received a complete response letter (CRL) stating that the agency…
Emicizumab (Hemlibra, Roche Holding AG), a costly new drug to treat the bleeding disorder hemophilia A, could significantly reduce health care expenses for certain patients, according to a draft report from an independent U.S. nonprofit organization that evaluates clinical and cost effectiveness of…

Pages

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA